Download: Evaluation of Therapies for Atopic Dermatitis

Evaluation of Therapies for Atopic Dermatitis
Evaluation of Therapies for Atopic Dermatitis
Evaluation of Therapies for Atopic Dermatitis

Improving Quality of Life for Over 3% of the World’s Population

When you are studying a condition that affects over 3% of the world population, as dermatitis does, you want to ensure your models are as predictive as possible. PharmaLegacy is a global leader in the development of highly predictive animal models. We have over 300 validated animal models, including non-human primate models and many humanized rodent models. Download our atopic dermatitis brochure and we’ll introduce you to some of our newest models. See why over 300 pharma & biopharma companies across the globe trust PharmaLegacy to perform their preclinical studies.

Evaluation of Therapies for Atopic Dermatitis
Evaluation of Therapies for Atopic Dermatitis